CHD Stock Forecast & Price Target

Church & Dwight Co is supported by a resilient, innovation-led portfolio that keeps driving volume growth, with 3Q organic sales up 5.1% versus 3% guidance and broad-based 4.6% volume growth. Its seven power brands and newer franchises like TheraBreath, Hero, Touchland, and Miss Mouth provide meaningful runway through distribution gains, international expansion, and category extensions, while Arm & Hammer and laundry share gains reinforce pricing power. Margin upside also looks durable as productivity, favorable mix, and operating leverage help offset inflation and transportation costs, supporting earnings growth of 7% for 2026 and 2027 and confidence in management’s execution.

Church & Dwight Co is viewed negatively because its business has slowed below historical growth rates as consumer weakness, elevated promotions, and weak category fundamentals limit volume and pricing power. Its outlook is further challenged by a lack of a clear U.S. inflection, low exposure to higher-growth international markets, and a valuation premium to peers, while Touchland is now expected to be flat in 2026 versus prior high-teens growth expectations. Competitive pressure, private-label risk, and execution risk from acquisitions could hold top-line growth near the downside case’s ~1.2% CAGR and constrain profit margins around ~19% through 2034.